Browsing by Author Mo, Zhaojun
Showing results 1 to 1 of 1
| Preview | Issue Date | Title | Author(s) |
|---|---|---|---|
 | 2022 | A multicenter, randomized, double-blinded, placebo-controlled Phase III trial to evaluate the efficacy, safety and immunogenicity of the recombinant two-component COVID-19 vaccine (CHO cell) in adults aged 18 years and older | Karki, Khem Bahadur; Mo, Zhaojun |